Sfoglia per Autore "Conrad, K."
Items 1-3 di 3
-
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
Rigopoulou, E. I.; Roggenbuck, D.; Smyk, D. S.; Liaskos, C.; Mytilinaiou, M. G.; Feist, E.; Conrad, K.; Bogdanos, D. P. (2012)Asialoglycoprotein receptor (ASGPR) has attracted the attention of liver immunologists for many years. This liver-specific lectin was found to be a major B and T cell autoantigenic target in patients with autoimmune liver ... -
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies
Bogdanos, D. P.; Rigopoulou, E. I.; Smyk, D. S.; Roggenbuck, D.; Reinhold, D.; Forbes, A.; Laass, M. W.; Conrad, K. (2011)Pancreatic autoantibodies (PAB) giving characteristic staining patterns of the exocrine pancreas by indirect immunoflourescence appear to be specific markers of Crohn's disease (CrD), being present in approximarely 30% of ... -
Ileal InflammationMay Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease
Pavlidis, P.; Romanidou, O.; Roggenbuck, D.; Mytilinaiou, M. G.; Al-Sulttan, F.; Liaskos, C.; Smyk, D. S.; Koutsoumpas, A. L.; Rigopoulou, E. I.; Conrad, K.; Forbes, A.; Bogdanos, D. P. (2012)Why zymogen glycoprotein 2 (GP2), the Crohn's disease (CD)-specific pancreatic autoantigen, is the major target of humoral autoimmunity in inflammatory bowel diseases (IBD) is uknown. Recent evidence demonstrates that GP2 ...